Overexpression of monocarboxylate transporter and lactate dehydrogenase alters insulin secretory responses to pyruvate and lactate in beta cells

Citation
H. Ishihara et al., Overexpression of monocarboxylate transporter and lactate dehydrogenase alters insulin secretory responses to pyruvate and lactate in beta cells, J CLIN INV, 104(11), 1999, pp. 1621-1629
Citations number
39
Categorie Soggetti
Medical Research General Topics
Journal title
JOURNAL OF CLINICAL INVESTIGATION
ISSN journal
00219738 → ACNP
Volume
104
Issue
11
Year of publication
1999
Pages
1621 - 1629
Database
ISI
SICI code
0021-9738(199912)104:11<1621:OOMTAL>2.0.ZU;2-F
Abstract
Previous investigations revealed low activities of lactate dehydrogenase (L DH) and plasma membrane monocarboxylate transporters (MCT) in the pancreati c beta cell. In this study the significance of these characteristics was ex plored by overexpressing type A LDH (LDH-A) and/or type 1 MCT (MCT-1) in th e clonal INS-1 beta cells and isolated rat islets. Inducible overexpression of LDH-A resulted in an 87-fold increase in LDH activity in INS-1 cells. A denovirus-mediated overexpression of MCT-1 increased lactate transport acti vity 3.7-fold in INS-1 cells. Although overexpression of LDH-A, and/or MCT- 1 did not affect glucose-stimulated insulin secretion, LDH-A overexpression resulted in stimulation of insulin secretion even at a low lactate concent ration with a concomitant increase in its oxidation in INS-1 cells regardle ss of MCT-1 co-overexpression. Adenovirus-mediated overexpression of MCT-1 caused an increase in pyruvate oxidation and conferred pyruvate-stimulated insulin release to isolated rat islets. Although lactate did not stimulate insulin secretion from control or MCT-l-overexpressing islets, co-overexpre ssion of LDH-A and MCT-1 evoked lactate-stimulated insulin secretion with a concomitant increase in lactate oxidation in rat islets. These results sug gest that low expression of MCT and LDH is requisite to the specificity of glucose in insulin secretion, protecting the organism from undesired hypogl ycemic actions of pyruvate and lactate during exercise and other catabolic states.